Contraline

Contraline has invented a proprietary hydrogel that is implanted into the vas deferens through a minimally invasive, outpatient procedure. The hydrogel works by blocking sperm from traveling through the vas deferens. The vas deferens are a pair of tubes that transport sperm. During a vasectomy, the vas deferens are permanently severed. Rather than cutting the tubes, Echo-VR is a polymer gel that is implanted inside, thus preserving the male reproductive tract. Similar to intrauterine devices (IUDs) for women, Contraline's contraceptive is designed to last for years and be reversible.

Contraline is a medical device company developing a long-lasting, non-hormonal, and reversible male contraceptive using advancements in hydrogel technology. The company was founded in 2015 by Kevin Eisenfrats and Dr. John Herr, and is headquartered in Charlottesville, Virginia. To learn more, visit http://www.contraline.com/.